T cell immunomodulation by clinically used allogeneic human cancellous bone fragments: a potential novel immunotherapy tool

El-Sherbiny, YM orcid.org/0000-0003-4791-3475, El-Jawhari, JJ orcid.org/0000-0002-0580-4492, Moseley, TA et al. (2 more authors) (2018) T cell immunomodulation by clinically used allogeneic human cancellous bone fragments: a potential novel immunotherapy tool. Scientific Reports, 8 (1). ARTN13535. ISSN 2045-2322

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2018, The Author(s). This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Dates:
  • Accepted: 17 August 2018
  • Published: 10 September 2018
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Orthopaedics (Leeds)
Funding Information:
FunderGrant number
Nuvasive INCNO EXT REF GIVEN
AO FoundationS-16-132E
Depositing User: Symplectic Publications
Date Deposited: 25 Sep 2018 15:36
Last Modified: 11 Oct 2018 14:35
Status: Published
Publisher: Nature Research
Identification Number: https://doi.org/10.1038/s41598-018-31979-1

Share / Export

Statistics